El Gobierno Español concede 5 millones de Euros a la Iniciativa de Investigación en Nuevos Medicamentos para Enfermedades Olvidadas (DNDi)

[ Ginebra, Segovia, Madrid – 6 de marzo de 2008 ]
La Agencia Española de Cooperación Internacional y Desarrollo (AECID) destina 5 millones de euros a la Iniciativa de Medicamentos para Enfermedades Olvidadas (DNDi por sus siglas en inglés), la cual lleva a cabo la investigación y el desarrollo de tratamientos esenciales para enfermedades como la Tripanosomiasis Africana, la Leishmaniasis, la enfermedad de Chagas o la malaria.

The US National Institutes of Health Awards DNDi with a 3-Year Grant Dedicated to the Development of a Low-Cost Treatment for Visceral Leishmaniasis

[ Geneva, Switzerland – November 5, 2007 ]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), has granted Drugs for Neglected Diseases initiative (DNDi) USD 2.3 million to be disbursed over 3 years for research and development that focuses on developing a low-cost formulation of amphotericin B to treat visceral leishmaniasis.

CIPIH Report could change the lives of neglected patients

[ Geneva – April 5, 2006 ]
DNDi welcomes the final report of the WHO’s Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH). The report clearly states that it is imperative for governments to set global health priorities and promote innovation to develop and deliver much-needed medicines, vaccines, and diagnostics adapted to the needs of the sick and neglected in developing countries.

DFID’s funding of DNDi in the news…

[Geneva –March 9, 2005 ]
UK government commits £6.5 million to DNDi’s research for new medicines for neglected diseases
RealHealthNews interview with Bernard Pecoul regarding DFID funding of DNDi.

The gap is growing: More resources needed now for neglected diseases

[ Geneva – November 11, 2004 ]
Two important conferences convene this month that will decide the future of patients suffering from neglected diseases in the poorer countries of the world: The Ministerial Summit on Health Research, November 16-20 in Mexico City, and the Dutch Government / WHO “Priority Medicines for the Citizens of Europe and the World” meeting, 18 November in The Hague.